Amgen Inc (AMGN-RM)

16,000.00
0.00(0.00%)
  • Volume:
    0
  • Bid/Ask:
    15,915.00/18,000.00
  • Day's Range:
    15,915.00 - 18,750.00
  • Type:Equity
  • Market:Russia
  • ISIN:US0311621009

AMGN-RM Overview

Prev. Close
17,556
Day's Range
15,915-18,750
Revenue
1.41T
Open
18,070
52 wk Range
13,916-18,750
EPS
-
Volume
0
Market Cap
8.09T
Dividend (Yield)
7.76
(N/A)
Average Volume (3m)
149
P/E Ratio
-
Beta
-
1-Year Change
-8.94%
Shares Outstanding
534,199,933
Next Earnings Date
-
What is your sentiment on Amgen?
or
Vote to see community's results!

Amgen Inc News

Amgen Inc Analysis

Amgen Inc Company Profile

Amgen Inc Company Profile

Employees
24300

Amgen Inc. is a biotechnology company. The Company discovers, develops, manufactures and delivers various human therapeutics. It operates in human therapeutics segment. Its marketed products portfolio includes Neulasta (pegfilgrastim); erythropoiesis-stimulating agents (ESAs), such as Aranesp (darbepoetin alfa) and EPOGEN (epoetin alfa); Sensipar/Mimpara (cinacalcet); XGEVA (denosumab); Prolia (denosumab); NEUPOGEN (filgrastim), and other marketed products, such as KYPROLIS (carfilzomib), Vectibix (panitumumab), Nplate (romiplostim), Repatha (evolocumab), BLINCYTO (blinatumomab), IMLYGIC (talimogene laherparepvec) and Corlanor (ivabradine). It focuses on human therapeutics for the treatment of serious illness in the areas of oncology/hematology, cardiovascular disease and neuroscience. Its product candidates in Phase III include Erenumab for episodic migraine, Aranesp for myelodysplastic syndromes, BLINCYTO for acute lymphoblastic leukemia and IMLYGIC for metastatic melanoma.

Read More

Technical Summary

Type
5 Min
15 Min
Hourly
Daily
Monthly
Moving Averages
Technical Indicators
Summary